Two drugmakers being sued by the city of Chicago for allegedly masking the downsides of opiate-based painkillers don’t want the city’s amended complaint to be unsealed in its entirety.
Cephalon Inc., a wholly owned subsidiary of Teva Pharamceuticals Industries Ltd., argues that unsealing all of the complaint would disclose confidential information including trade secrets about its Fentora painkiller.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
